Zobrazeno 41 - 50
of 173
pro vyhledávání: '"Peer Christiansen"'
Publikováno v:
Clinical Epidemiology
Christiansen, P, Ejlertsen, B, Jensen, M-B & Mouridsen, H 2016, ' Danish Breast Cancer Cooperative Group ', Clinical epidemiology, vol. 8, pp. 445-449 . https://doi.org/10.2147/CLEP.S99457
Christiansen, P, Ejlertsen, B, Jensen, M-B & Mouridsen, H 2016, ' Danish Breast Cancer Cooperative Group ', Clinical epidemiology, vol. 8, pp. 445-449 . https://doi.org/10.2147/CLEP.S99457
AIM OF DATABASE: Danish Breast Cancer Cooperative Group (DBCG), with an associated database, was introduced as a nationwide multidisciplinary group in 1977 with the ultimate aim to improve the prognosis in breast cancer. Since then, the database has
Autor:
Deirdre Cronin-Fenton, Peer Christiansen, Thomas P. Ahern, Rulla M. Tamimi, Timothy L. Lash, Sinna Pilgaard Ulrichsen, Bernard F. Cole, Anne Broe, Per Damkier, Henrik Toft Sørensen
Publikováno v:
Ahern, T P, Broe, A, Lash, T L, Cronin-Fenton, D P, Ulrichsen, S P, Christiansen, P M, Cole, B F, Tamimi, R M, Sørensen, H T & Damkier, P 2019, ' Phthalate Exposure and Breast Cancer Incidence : A Danish Nationwide Cohort Study ', Journal of Clinical Oncology, vol. 37, no. 21, pp. 1800-1809 . https://doi.org/10.1200/JCO.18.02202
Ahern, T P, Broe, A, Lash, T L, Cronin-Fenton, D P, Ulrichsen, S P, Christiansen, P M, Cole, B F, Tamimi, R M, Sørensen, H T & Damkier, P 2019, ' Phthalate exposure and breast cancer incidence : A danish nationwide cohort study ', Journal of Clinical Oncology, vol. 37, no. 21, pp. 1800-1809 . https://doi.org/10.1200/JCO.18.02202
Ahern, T P, Broe, A, Lash, T L, Cronin-Fenton, D P, Ulrichsen, S P, Christiansen, P M, Cole, B F, Tamimi, R M, Sørensen, H T & Damkier, P 2019, ' Phthalate exposure and breast cancer incidence : A danish nationwide cohort study ', Journal of Clinical Oncology, vol. 37, no. 21, pp. 1800-1809 . https://doi.org/10.1200/JCO.18.02202
PURPOSE Phthalate exposure is ubiquitous and especially high among users of drug products formulated with phthalates. Some phthalates mimic estradiol and may promote breast cancer. Existing epidemiologic studies on this topic are small, mostly not pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05a69c28eef6fc0dcb8e38280a949e8e
https://pure.au.dk/portal/da/publications/phthalate-exposure-and-breast-cancer-incidence(d060b0ed-1e04-41c0-bbc1-a4e733d2d5f7).html
https://pure.au.dk/portal/da/publications/phthalate-exposure-and-breast-cancer-incidence(d060b0ed-1e04-41c0-bbc1-a4e733d2d5f7).html
Publikováno v:
Zøylner, I A, Lomborg, K, Christiansen, P M & Kirkegaard, P 2019, ' Surgical breast cancer patient pathway : Experiences of patients and relatives and their unmet needs ' Health Expectations, vol. 22, no. 2, pp. 262-272 . https://doi.org/10.1111/hex.12869
Health Expectations : An International Journal of Public Participation in Health Care and Health Policy
Zøylner, I A, Lomborg, K, Christiansen, P M & Kirkegaard, P 2019, ' Surgical breast cancer patient pathway : Experiences of patients and relatives and their unmet needs ', Health Expectations, vol. 22, no. 2, pp. 262-272 . https://doi.org/10.1111/hex.12869
Health Expectations : An International Journal of Public Participation in Health Care and Health Policy
Zøylner, I A, Lomborg, K, Christiansen, P M & Kirkegaard, P 2019, ' Surgical breast cancer patient pathway : Experiences of patients and relatives and their unmet needs ', Health Expectations, vol. 22, no. 2, pp. 262-272 . https://doi.org/10.1111/hex.12869
BACKGROUND AND AIM: Breast cancer is the most common cancer disease in women worldwide. In Denmark, the law prescribes cancer patient pathways (CPPs) in general and thus also for breast cancer. Although results from patient satisfaction surveys show
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ce3059ce853c6e37c1cd9389c5af268
https://pure.au.dk/portal/da/publications/surgical-breast-cancer-patient-pathway(d353a060-a6cf-4891-ab29-e63cb0c22431).html
https://pure.au.dk/portal/da/publications/surgical-breast-cancer-patient-pathway(d353a060-a6cf-4891-ab29-e63cb0c22431).html
Autor:
Trine Tramm, Peer Christiansen, Anne Bodilsen, Hanne Melgaard Nielsen, Jonas Amstrup Funder, Anne Schmidt Sorensen, Marco Mele, Josephine Bruun
Publikováno v:
Mele, M, Sørensen, A S, Bruun, J, Funder, J A, Tramm, T, Bodilsen, A, Nielsen, H M & Christiansen, P M 2019, ' Inflammatory breast cancer : A review from our experience ', Breast Disease, vol. 38, no. 2, pp. 47-55 . https://doi.org/10.3233/BD-180365
INTRODUCTION: Inflammatory Breast Cancer (IBC) is a distinct and rare type of breast cancer accounting for up to 6% of all breast cancer cases in Europe. The aim of this study was to investigate diagnostic methods, treatments, and outcome after IBC i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c2fde238c6e05cc881054e1f438ab79
https://pure.au.dk/portal/da/publications/inflammatory-breast-cancer(c3af6599-1a4d-4e37-8e81-962726ba1a64).html
https://pure.au.dk/portal/da/publications/inflammatory-breast-cancer(c3af6599-1a4d-4e37-8e81-962726ba1a64).html
Autor:
Per Damkier, Thomas P. Ahern, Stephen Hamilton-Dutoit, Anders Kjærsgaard, Lindsay J Collin, Peer Christiansen, Kristina B. Christensen, Deirdre Cronin-Fenton, Kristina Lystlund Lauridsen, Timothy L. Lash, Henrik Toft Sørensen, Rami Yacoub
Publikováno v:
Collin, L J, Cronin-Fenton, D P, Ahern, T P, Christensen, K B, Damkier, P, Hamilton-Dutoit, S, Kjaersgaard, A, Lauridsen, K L, Yacoub, R, Christiansen, P, Sørensen, H T & Lash, T L 2019, ' Expression of survivin does not appear to influence breast cancer recurrence risk ', Acta Oncologica, vol. 58, no. 2, pp. 154-161 . https://doi.org/10.1080/0284186X.2018.1503419
BACKGROUND: Survivin is an inhibitor of apoptosis, and its expression associates with poor outcomes in multiple cancers. It may be a therapeutic target due to its unique expression in cancer cells.METHODS: We estimated the association between nuclear
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11c5d4567c22bdcc224bb419fa7029e9
https://pure.au.dk/portal/da/publications/expression-of-survivin-does-not-appear-to-influence-breast-cancer-recurrence-risk(8edf1125-b428-4628-b8be-a770a766d5de).html
https://pure.au.dk/portal/da/publications/expression-of-survivin-does-not-appear-to-influence-breast-cancer-recurrence-risk(8edf1125-b428-4628-b8be-a770a766d5de).html
Publikováno v:
Zøylner, I A, Kirkegaard, P, Christiansen, P M & Lomborg, K 2020, ' Patient involvement in the development of the Danish surgical breast cancer patient pathway – An action research project ', Action Research . https://doi.org/10.1177/1476750320960819
Although patient involvement is on the political agenda, the influence on clinical practice is poorly described. The aim of this study was to explore and evaluate the participatory process of involving patients and relatives in development of a surgi
Publikováno v:
Bodilsen, A, Offersen, B V, Christiansen, P & Overgaard, J 2016, ' Pattern of relapse after breast conserving therapy, a study of 1519 early breast cancer patients treated in the Central Region of Denmark 2000-2009 ', Acta Oncologica, pp. 1-6 . https://doi.org/10.3109/0284186X.2016.1167955
BACKGROUND: The continuous improvements in diagnosing and treatment of breast cancer are reflected in the ever changing pattern of recurrence. The aim of the study was to investigating recurrence pattern and prognostic factors of recurrence in a popu
Autor:
Lida Pistioli, Peer Christiansen, Christos Markopoulos, Christina Hedin, Daniel Tegnelius, Nils Ryegaard Rasmussen, Leif Bergkvist, Malin Sund, Hjørdis Jørnsgård, Andreas Karakatsanis, Staffan Eriksson, Kosmas Daskalakis, Fredrik Wärnberg, Lone Fischer
Publikováno v:
Breast Cancer Research and Treatment
Karakatsanis, A, Christiansen, P M, Fischer, L, Hedin, C, Pistioli, L, Sund, M, Rasmussen, N R, Jørnsgård, H, Tegnelius, D, Eriksson, S, Daskalakis, K, Wärnberg, F, Markopoulos, C J & Bergkvist, L 2016, ' The Nordic SentiMag trial : a comparison of super paramagnetic iron oxide (SPIO) nanoparticles versus Tc(99) and patent blue in the detection of sentinel node (SN) in patients with breast cancer and a meta-analysis of earlier studies ', Breast Cancer Research and Treatment . https://doi.org/10.1007/s10549-016-3809-9
Karakatsanis, A, Christiansen, P M, Fischer, L, Hedin, C, Pistioli, L, Sund, M, Rasmussen, N R, Jørnsgård, H, Tegnelius, D, Eriksson, S, Daskalakis, K, Wärnberg, F, Markopoulos, C J & Bergkvist, L 2016, ' The Nordic SentiMag trial : a comparison of super paramagnetic iron oxide (SPIO) nanoparticles versus Tc(99) and patent blue in the detection of sentinel node (SN) in patients with breast cancer and a meta-analysis of earlier studies ', Breast Cancer Research and Treatment . https://doi.org/10.1007/s10549-016-3809-9
The aim of the study is to compare the efficacy of SPIO as a tracer in sentinel node biopsy (SNB) in breast cancer with Tc and patent blue in a multicentre prospective study and perform a meta-analysis of all published studies. It also aims to follow
Autor:
Tinne Laurberg, Christina D Lyngholm, Peer Christiansen, Tine Engberg Damsgaard, Jan Alsner, Jens Overgaard
Publikováno v:
Lyngholm, C D, Laurberg, T, Alsner, J, Damsgaard, T E, Overgaard, J & Christiansen, P 2016, ' Failure pattern and survival after breast conserving therapy. Long-term results of the Danish Breast Cancer Group (DBCG) 89 TM cohort ', Acta Oncologica, vol. 55, no. 8, pp. 983-992 . https://doi.org/10.3109/0284186X.2016.1156741
Based on the results from the DBCG 82 trial, breast conserving therapy (BCT) has been implemented as standard in Denmark since 1989, and today constitutes more than 70% of the primary treatment. Our aim was to evaluate the implementation of BCT as a
Autor:
Jens Overgaard, Peer Christiansen, Bent Ejlertsen, Nikolaj Amby, Anne Bodilsen, Pernille Vahl, J Michael Dixon, Birgitte Vrou Offersen, Karsten Bjerre
Publikováno v:
Journal of Surgical Oncology. 113:609-615
Background and Method The association between margin width and ipsilateral breast tumour recurrence (IBTR, defined as invasive recurrence) was investigated in a population-based nationwide cohort of 11,900 patients undergoing breast-conserving therap